Influence of pertussis toxin on superficial bladder carcinoma in rats

Urological Research

Volumn 30, Issue 3, 2002, Pages 199-203

  Lümmen, Gerd ^a   Sperling, Herbert ^a   Eisenhardt, Andreas ^a   Vom Dorp, Frank ^a   Otto, Thomas ^a   Rübben, Herbert ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

G protein coupled receptors; N butyl N (4 hydroxybutyl)nitrosamine; Pertussis toxin; Transitional cell carcinoma

Indexed keywords

N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; PERTUSSIS TOXIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

ANIMALS; BODY WEIGHT; BUTYLHYDROXYBUTYLNITROSAMINE; CARCINOMA, TRANSITIONAL CELL; FEMALE; PERTUSSIS TOXIN; RATS; RATS, WISTAR; URINARY BLADDER NEOPLASMS; URINE;

EID: 0036924205     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-002-0250-9     Document Type: Article

References (32)

1. Babaya K, Takahashi S, Momose H, Matsuki H, Sasaki K, Samma S, Ozono S, Hirao Y, Okajima E (1987) Effects of single chemotherapeutic agents on development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in rats. Urol Res 15:329
2. Bex A, Lümmen G, Rembrink K, Otto T, Metz K, Rübben H (1998) Influence of pertussis toxin on local progression and metastasis after orthotopic implantation of the human prostate cancer cell line PC3 in nude mice. Prost Cancer Prost Dis 5:1
3. Dhanasekaran N, Tsim ST, Dermott JM, Onesime D (1998) Regulation of cell proliferation by G proteins. Oncogene 17:1383
4. Faller DV (1988) Diseases of the spleen. In: Wyngaarden JB, Smith LH (eds) Cecil - Textbook of medicine. WB Saunders, Philadelphia, p 1039
5. Hermouet S, de Mazancourt P, Spiegel AM (1993) Mitogenic effects of pertussis toxin-sensitive G-protein alpha subunits: the mitogenic action of alpha i2 in NIH 3T3 cells is mimicked by alpha i1, but not alpha i3. Cell Signal 5:215
6. Hermouet S, Aznavoorian S, Spiegel AM (1996) In vitro and in vivo growth inhibition of murine melanoma K-1735 cell by a dominant negative mutant alpha subunit of the Gi2 protein. Cell Signal 8:149
7. Irving CC, Murphy WM, Damil DS (1984) Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C5BL/6xDBA/2) F1 mice. J Natl Cancer Inst 73:753
8. Ito N, Hiasa Y, Tamai A, Okajima E, Kitamura H (1969) Histogenesis of urinary bladder tumors induced by n-butyl-n(4-hydroxy-butyl)nitrosamin in rats. Gann 60:401
9. Kaubisch S, Lum BL, Reese J, Freiha F, Torti FM (1991) Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion. J Urol 146:28
10. Krege S, Giani G, Meyer R, Otto T, Rübben H, and participating clinics (1996) A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transuretheral resection only versus transuretheral resection plus mitomycin C versus transuretheral resection plus bacillus Calmette-Guérin. J Urol 156:962
11. Kroft SH, Oyasu R (1994) Urinary bladder cancer: mechanisms of development and progression. Lab Invest 71:158
12. Liotta LA, Starcke ML, Aznavoorian SA, Beckner ME, Schiffman E (1991) Tumor cell motility. Semin Cancer Biol 2:111
13. Lundholm C, Norlén BJ, Ekman P, Jahnson S, Lagerkvist M, Lindeborg T, Olsson JL, Tveter K, Wijkstrom H, Westberg R, Malmström PU (1996) A randomized prospective study comparing long-term intravesical instillations of mitomycin C and bacillus Calmette-Guérin in patients with superficial bladder carcinoma. J Urol 156:372
14. Lümmen G, Virchow S, Rümenapp U, Schmidt M, Wieland T, Otto T, Rübben H, Jakobs KH (1997) G protein-coupled receptor stimulated migration of human transitional cell carcinoma cell line J82. Naunyn Schmiedebergs Arch Pharmacol 356:769
15. Ohtani M, Fukukshima S, Okamura T, Sakata T, Ito N, Koiso K, Niijima T (1984) Effects of intravesical instillation of antitumor chemotherapeutic agents on bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer 54:1525
16. Ohtani M, Kakizoe T, Nishio Y, Sato S, Sugimara T, Fukushima S, Niijima T (1986) Sequential changes of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Res 46:2001
17. Otto T, Birchmeier W, Schmidt U, Rembrink K, Schmidt J, Rübben H, Raz A (1994) Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with carcinoma of the bladder. Cancer Res 54:3120
18. Otto T, Bex A, Schmidt U, Raz A, Rübben H (1997) Improved prognosis assessment for patients with bladder carcinoma. Am J Pathol 150:1919
19. Otto T, Lümmen G, Riedmiller H, Kälble T, Krege S, Rübben H (1999) Neoadjuvant therapy with pertussis toxine (PTX) prior to radical cystectomy in bladder cancer patients. - A randomized phase II study. Urology 54:458
20. Otto T, Lümmen G, Bex A, Rübben H, Raz A (1999) Tumor cell motility. A novel therapeutic target in bladder carcinoma, experimental and clinica results. Adv Exp Med Biol 463:469
21. Pawinsky A, Sylvester R, Kurth KH, Bouffioux C, van der Meijden A, Parmar MKB, Bijnens L (1996) A combined analysis of European organization for research and treatment of cancer, and medical research council randomized clinical trials for the prophylactic treatment of stage Ta/T1 bladder cancer. J Urol 156:1934
22. Radhika V, Dhanasekaran N (2001) Transforming G proteins. Oncogene 20:1607
23. Raghavan D, Shipley WU, Garnik MB, Russel PJ, Richie JP (1990) Biology and management of bladder cancer. N Engl J Med 322:1129
24. Recker F, Otto T (1991) Tierexperimentelle Aspekte des Blasenkarzinoms. Urologe A 30:172
25. Roos E, van de Pavert IV (1987) Inhibition of lymphoma invasion and liver metastasis formation by pertussis toxin. Cancer Res 47:5439
26. Rübben H, Otto T (2000) Harnblasenkarzinom. In: Rübben H (ed) Uroonkologie. Springer, Berlin Heidelberg New York, p 85
27. Rümenapp U, Lümmen G, Virchow S, Hanske J, Meyer zu Heringdorf D, Jakobs KH (2000) Sphingolipid receptor signalling and function in human bladder carcinoma cells: inhibition of LPA - but enhancement of thrombin-stimulated cell motility. Naunyn Schmiedebergs Arch Pharmacol 361:1
28. Stoker M, Gherardi E (1991) Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta 1072:81
29. Stossel TP (1993) On the crawling of animal cells. Science 260:1086
30. Tanaka S, Kudoh S, Mollik AU, Kudoh T, Kogawa T, Suzuki T (1992) Histological study on intravesical instillation of Bacillus Calmette Guerin (BCG) and adriamycin for BBN-induced bladder tumor in rats (in Japanese). Nippon Hinyokika Gakkai Zasshi 83:368
31. Van Roy F, Mareel M (1992) Tumor invasion: effects of cell adhesion and motility. Trends Cell Biol 2:163
32. Witjes JA, van der Meiden APM, Collette L, Sylvester R, Debruyne FMJ, van Aubel A, Witjes WP, and the EORTC GU Group and the Dutch South East Cooperative Urological Group (1998) Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille CalmetteGuérin-RIVM and mitomycin C in superficial bladder cancer. Urology 52:403